Open AccessEfficacy of Atorvastatin in Prevention of Contrast-induced Nephropathy in High-risk Patients Undergoing Angiography: A Double-blind Randomized Controlled Trial
Author(s) -
Maaz Hussain Syed,
Prakash Narayan Khandelwal,
Vijay Thawani,
Sagar Katare
Publication year - 2017
Publication title -
journal of pharmacology and pharmacotherapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.301
H-Index - 34
eISSN - 0976-5018
pISSN - 0976-500X
DOI - 10.4103/jpp.jpp_156_16
Subject(s) - medicine , atorvastatin , contrast induced nephropathy , randomized controlled trial , nephropathy , creatinine , group b , urology , angiography , gastroenterology , surgery , endocrinology , diabetes mellitus
To evaluate the efficacy and safety of atorvastatin (ATN) 80 mg in the prevention of contrast medium- induced nephropathy (CIN) in high risk patients undergoing angiograph.